Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 10144
  • 10145
  • 10146
  • …
  • ›
  • »

2025-06-05

Restart Life Sciences Corp.: Restart Life Introduces BrainBalls Product Line

2025-06-05

VSBLTY Announces Two Letters Of Intent For Smart Community Security In LATAM

2025-06-05

Fevertree Drinks anticipates low single-digit revenue growth for 2025

2025-06-05

EQS-News: ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease

2025-06-05

Circio Holding ASA: Minutes from the annual general meeting 2025

2025-06-05

Direct Communication Solutions, Inc.: DCS Announces Resignation and Appointment of New Director

2025-06-05

Blue Sky Uranium launches $1.02M private placement offering

2025-06-05

New Strong Buy Stocks for June 5th

2025-06-05

Abu Dhabi€s IRH Buys Majority Stake In Alphamin€s Tin Operations In $366 Million Deal

2025-06-05

ROK Resources, Inc.: ROK Resources Announces Normal Course Issuer Bid

2025-06-05

FDA grants breakthrough therapy status for Cellectar′s iopofosine I 131

2025-06-05

Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025

  • «
  • ‹
  • …
  • 10144
  • 10145
  • 10146
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 29/Apr/2026 11:30:43
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies